Literature DB >> 18298899

Beta-sitosterol sensitizes MDA-MB-231 cells to TRAIL-induced apoptosis.

Cheol Park1, Dong-oh Moon, Chung-ho Ryu, Byung tae Choi, Won ho Lee, Gi-young Kim, Yung hyun Choi.   

Abstract

AIM: To investigate whether subtoxic concentration of beta-sitosterol (SITO) combined with TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in TRAIL-resistant MDA-MB-231 breast cancer cells.
METHODS: Cell viability and growth were assessed by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphnyl-2H-tetrazolim bromide assays, chromatin condensation, release of lactate dehydrogenase (LDH), and Annexin V+ cells. The apoptosis-related proteins were detected by Western blotting.
RESULTS: Treatment with TRAIL in combination with subtoxic concentrations of SITO sensitized MDA-MB-231 breast cancer cells to TRAIL-mediated apoptosis. The synergistic treatment induced chromatin condensation, DNA fragmentation, the release of LDH, and Annexin V+ cells. The indicators of apoptosis are correlated to the induction of caspase activities, which results in the cleavage of poly(ADP-ribose)polymerase. Both the cytotoxic effects and apoptotic characteristics induced by the synergistic treatment were significantly inhibited by a pan-caspase inhibitor z-VAD-fmk, demonstrating the important role of caspases. These results indicate that caspases are crucial regulators of apoptosis induced by the combined treatment of SITO and TRAIL in MDA-MB-231 cells.
CONCLUSION: The synergistic treatment of SITO and TRAIL induces apoptosis, which can serve as a potential preventive and therapeutic agent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18298899     DOI: 10.1111/j.1745-7254.2008.00761.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  13 in total

1.  Identification and characterization of β-sitosterol target proteins.

Authors:  Brett Lomenick; Heping Shi; Jing Huang; Chuo Chen
Journal:  Bioorg Med Chem Lett       Date:  2015-03-11       Impact factor: 2.823

2.  Noncanonical Cell Death Induction by Reassortant Reovirus.

Authors:  Roxana M Rodríguez Stewart; Vishnu Raghuram; Jameson T L Berry; Gaurav N Joshi; Bernardo A Mainou
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

3.  7α-Hydroxy-β-Sitosterol from Chisocheton tomentosus Induces Apoptosis via Dysregulation of Cellular Bax/Bcl-2 Ratio and Cell Cycle Arrest by Downregulating ERK1/2 Activation.

Authors:  Mohammad Tasyriq; Ibrahim A Najmuldeen; Lionel L A In; Khalit Mohamad; Khalijah Awang; Noor Hasima
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-11       Impact factor: 2.629

Review 4.  Plant sterols as anticancer nutrients: evidence for their role in breast cancer.

Authors:  Bruce J Grattan
Journal:  Nutrients       Date:  2013-01-31       Impact factor: 5.717

5.  Evaluation of antioxidant and anticancer activity of extract and fractions of Nardostachys jatamansi DC in breast carcinoma.

Authors:  Shilpee Chaudhary; Kodangala Subraya Chandrashekar; Karkala Sreedhara Ranganath Pai; Manganahalli Manjunath Setty; Raviraj Anand Devkar; Neetinkumar Dnyanoba Reddy; Muhammed Haneefa Shoja
Journal:  BMC Complement Altern Med       Date:  2015-03-10       Impact factor: 3.659

6.  A humanized leucine zipper-TRAIL hybrid induces apoptosis of tumors both in vitro and in vivo.

Authors:  Dmitri Rozanov; Paul Spellman; Alexei Savinov; Alex Y Strongin
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

Review 7.  The Search for Putative Hits in Combating Leishmaniasis: The Contributions of Natural Products Over the Last Decade.

Authors:  Patrick O Sakyi; Richard K Amewu; Robert N O A Devine; Emahi Ismaila; Whelton A Miller; Samuel K Kwofie
Journal:  Nat Prod Bioprospect       Date:  2021-07-14

8.  Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axis.

Authors:  Junaid Abdulghani; Joshua E Allen; David T Dicker; Yingqiu Yvette Liu; David Goldenberg; Charles D Smith; Robin Humphreys; Wafik S El-Deiry
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

9.  Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells.

Authors:  Weiqiang Zhou; Xiuyan Feng; Shanchun Guo; Guangdi Wang
Journal:  Sci Rep       Date:  2016-06-13       Impact factor: 4.379

10.  Analysis of Molecular Mechanism of Erxian Decoction in Treating Osteoporosis Based on Formula Optimization Model.

Authors:  Lang Yang; Liuyi Fan; Kexin Wang; Yupeng Chen; Lan Liang; Xuemei Qin; Aiping Lu; Peng Cao; Bin Yu; Daogang Guan; Junxiang Peng
Journal:  Oxid Med Cell Longev       Date:  2021-06-18       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.